---
figid: PMC9497977__curroncol-29-00512-g007
pmcid: PMC9497977
image_filename: curroncol-29-00512-g007.jpg
figure_link: /pmc/articles/PMC9497977/figure/curroncol-29-00512-f007/
number: Figure 7
figure_title: ''
caption: CI-1040 inhibits MEK/ERK pathway genes. (Aâ€“E) Gene expression analysis of
  different MAPK pathway and apoptosis related genes in response to CI-1040 treatment
  in SH-SY5Y cells. (A) MAPK1. (B) MAPK2. (C) ERK2. (D) BCL-2. (E) c-JUN. (F,G) Western
  blot analysis of total ERK1/2 and pERK1/2 (Thr202/Tyr204) in response to CI-1040
  treatment. (F) Representative western blot images. (G) Densitometric analysis of
  pERK1/2 protein band as shown in F. * p < 0.05, ** p < 0.01, *** p < 0.001, and
  **** p < 0.0001.
article_title: Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma
  Growth.
citation: Rameswari Chilamakuri, et al. Curr Oncol. 2022 Sep;29(9):6508-6522.
year: '2022'

doi: 10.3390/curroncol29090512
journal_title: Current Oncology
journal_nlm_ta: Curr Oncol
publisher_name: MDPI

keywords:
- pediatric cancer
- neuroblastoma
- CI-1040
- PD184352
- signaling pathway
- drug repurposing

---
